<html xmlns="http://www.w3.org/1999/xhtml"><head> <style type="text/css">
         	     		 
         	    a                          {background : #ffffff; }
         	    article                    {border-style : dotted; border-width : 2px; }
         		 	
         		 	div                        {background : #ffffcc;}
         		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
         		 	div.ack                    {border-style : solid ; border-color : red; margin
         : 2em; }
         		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin
         1em;}
         		 	div.boxed-text             {margin : 5em; border-style : solid;}
         		 	div.contrib-group          {margin : 1em; }
         		 	div.fig                    {border-style : solid; border-width : 2px; margin :
         2em; }
         		 	div.funding                {font-weight : bold ; font-size : 16pt;}
         		 	div.given-names            {font-style : italic;}
         		 	div.intro                  {border-style : inset; margin : 5px;}
         		 	div.introduction           {border-style : inset; margin : 5px;}
         		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin
         1em;}
         		 	div.journal-title-group    {background : #ffeeee;}
         		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
         		 	div.kwd                    {font-style : italic}
         		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
         		 	div.name                   {font-weight : bold;}
         		 	div.alt-title              {font-style : italic; font-size : 12px;}
         		 	
         		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
         		 	div.title                  {font-family : courier; font-weight : bold;
         		 	                            font-size : 16pt; margin : 5px;}
         		 	
         		 	div.materials_methods      {border-style : double; margin : 5px; }
         		 	div.methods                {border-style : double; margin : 5px; }
         		 	
         		 	div.results                {border-style : solid; margin : 5px;}
         		 	div.background             {border-style : dotted; margin : 5px;}
         		 	
         		 	div.discussion             {border-style : groove; margin : 5px;}
         		 	div.conclusion             {border-style : ridge; margin : 5px;}
         		 	div.conclusions             {border-style : ridge; margin : 5px;}
         		 	div.supplementary-material {border-style : inset; margin : 5px;}
         		 	div.abbreviations          {border-style : double; border-color : red; margin
         : 5px;}
         		 	div.competinginterests     {border-style : double; border-color : blue; margin
         : 5px;}
         		 	div.acknowledgements       {border-style : double; border-color : green; margin
         : 5px;}
         		 	div.authors_contributions   {border-style : double; border-color : purple; margin
         : 5px;}
         		 	
         		 	div.publisher              {border-style : outset; margin : 5px;}
         		 	div.fn-type-conflict       {background : #f88; }
         		 	div.fn-type-con            {background : #ddf; }
         		 	div.fn-type-other          {background : #ddd; }
         		 	
         		 	div.unknown                {background : #ffd;
         									 	  border-style : solid;
         									 	  border-width : 1px;
         									 	  padding : 2 px;}
         		 	  
         	    table                      {background : #ffffdd;}
         		 	tr                         {background : #ddddff; padding : 1px;}
         		 	
         		 	span                       {background : #ffcccc;}
         		 	
         		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
         		 	span.collab                {background : #ddffff; }
         		 	span.comment               {font-family : courier; font-size : 6px; background
         : #ffaaff;}
         		 	span.contrib               {background : #ffffff;}
         		 	span.corresp               {background : #ddffdd; }
         		 	span.doi                   {background : #ffffff;}
         		 	span.email                 {font-family : courier; }
         		 	span.etal                  {font-style : italic;}
         		 	span.fpage                 {font-family : courier;}
         		 	span.given-names           {background : #ffffff;}
         		 	span.iso-abbrev            {background : #ffffff;}
         		 	span.issn-epub             {background : #ffffff;}
         		 	span.issn-ppub             {background : #ffffff;}
         		 	span.journal-title         {background : #ffffff;}
         		 	span.lpage                 {font-family : courier;}
         		 	span.mixed-article-title   {font-style : italic ;}
         		 	span.nlm-ta                {background : #ffffff;}
         		 	span.pmc                   {background : #ffffff;}
         		 	span.pmcid                 {background : #ffffff;}
         		 	span.pmid                  {background : #ffffff;}
         		 	span.publisher             {background : #ffffff;}
         		 	span.publisher-id          {background : #ffffff;}
         		 	span.publisher-name        {background : #ffffff;}
         		 	span.source                {background : #ffffff;}
         		 	span.subject               {background : #ffffff;}
         		 	span.surname               {background : #ffffff;}
         		 	span.volume                {font-family : courier; font-weight : bold;}
         		 	span.year                  {font-family : courier ; font-style : italic;}
         			
      </style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"> <span class="nlm-ta" title="nlm-ta">Dialogues Clin Neurosci</span> <span class="iso-abbrev" title="iso-abbrev">Dialogues Clin Neurosci</span> <span class="pmc" title="pmc">Dialogues Clin Neurosci</span> <div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"> <span class="journal-title" tagx="journal-title" title="journal-title">Dialogues in Clinical Neuroscience</span> </div> <span class="issn-ppub" tagx="issn" title="issn-ppub">1294-8322</span> <span class="issn-epub" tagx="issn" title="issn-epub">1958-5969</span> <div class="publisher" tagx="publisher" title="publisher"> <span class="publisher-name" tagx="publisher-name" title="publisher-name">Les Laboratoires Servier</span> <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">France</span> </div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"> <span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/6787535">6787535</a> </span> <span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/31636493">31636493</a> </span> <span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.31887/DCNS.2019.21.2/vhede">10.31887/DCNS.2019.21.2/vhede</a> </span> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Original Article</span> </div> <div class="title-group"> <div class="article-title" title="article-title">
Treating psychiatric symptoms and disorders with non-psychotropic medications  </div> <span class="trans-title-group" tagx="trans-title-group" title="trans-title-group"> <span class="trans-title" tagx="trans-title" title="trans-title">spanish title</span> </span> <span class="trans-title-group" tagx="trans-title-group" title="trans-title-group"> <span class="trans-title" tagx="trans-title" title="trans-title">french title</span> </span> </div> <div class="contrib-group" title="contrib-group"> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Hede</span> <span class="given-names" tagx="given-names" title="given-names">Vincent</span> </span> <span class="degrees" tagx="degrees" title="degrees">MD</span> <span class="citation_author_institution" id="">[], </span> </span> </div> <div class="contrib-group" title="contrib-group"> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Devillé</span> <span class="given-names" tagx="given-names" title="given-names">Cédric</span> </span> <span class="degrees" tagx="degrees" title="degrees">MD</span> <span class="citation_author_institution" id="">[], </span> </span> </div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp">
Dr Vincent Hede, Hôpitaux Universitaires de Genève, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. <span class="label" tagx="label" title="label">*</span> E-mail: <span class="email" tagx="email" title="email">Vincent.Hede@hcuge.ch</span> </div> </div> <span class="pub-date-epub-ppub" title="pub-date-epub-ppub">epub-ppub: <span>2019-6</span> </span> <span class="pub-date-ppub" title="pub-date-ppub">ppub: <span>2019-6</span> </span> <span class="volume" tagx="volume" title="volume">21</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">193</span> <span class="lpage" tagx="lpage" title="lpage">201</span> <div class="permissions"> <span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2019</span> </span> <span class="license" title="license"> <span class="license-p" title="license-p">This is an open-access article distributed under the terms of the Creative Commons Attribution License ( <a href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> </span> </div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p>A few drugs prescribed in internal medicine, ie, non-psychotropic drugs, can be used to treat certain neuropsychiatric disorders. For most of these situations, the level of evidence remains low. But when sufficient data becomes available, these molecules are then included in official guidelines for the treatment of neuropsychiatric disorders. In this article we review interesting drugs which may be relevant from an evidence-based medicine point of view, and could become part of psychiatric practice in the future.  </p> </div> <span class="trans-abstract" tagx="trans-abstract" title="trans-abstract"> <p>Mettre la traduction ES</p> </span> <span class="trans-abstract" tagx="trans-abstract" title="trans-abstract"> <p>Mettre la traduction FR</p> </span> <div class="kwd-group"> <div class="kwd" title="kwd"> <i>non-psychotropic medication</i> </div> <div class="kwd" title="kwd"> <i>psychiatric disorder</i> </div> <div class="kwd" title="kwd"> <i>psychopharmacology</i> </div> <div class="kwd" title="kwd"> <i>evidence-based medicine</i> </div> </div> </div> </div> <div class="body" title="body"> <div class="introduction " title="sec"> <div class="title" tagx="title" title="title">
Introduction </div> <p> Psychotropic medications (PMs) are, according to a formal definition, drugs that affect mental and psychological functions. Many non-psychotropic medications (non-PMs) prescribed for physical (ie, non-psychiatric) diseases also influence brain function, and this influence can be beneficial. In this review, we label as non-PM all drugs for which the main indication does not belong to the field of psychiatry. Here, we discuss several non-PMs that are or might be useful in psychiatry, by improving a psychiatric disorder or symptom in the absence of any physical disease. These benefits have either been known for decades or they are new observations, as with statins. These situations share a common point which concerns the confirmation and validation of non-PM use in psychiatry; this path toward evidence-based medicine is sometimes tortuous.  </p> <p> The study of these molecules has several advantages. First, it provides alternative drugs, which can be scarce in psychiatry. They can be alternatives with fewer side effects in disorders for which there already exist treatments, or alternatives for disorders for which there are no sufficiently efficacious drugs, such as in Alzheimer disease (AD), or autism spectrum disorder (ASD). Second, these molecules have been used for a long time, and there is consequent knowledge about the tolerance and risk profile. Third, it provides potential new drug indications with minimal development cost. Fourth, using non-PMs to treat psychiatric disorders necessarily leads to questioning their mechanisms of action and, in so doing, lead to a better understanding of the pathophysiology of psychiatric disorders.  </p> </div> <div class="non-psychotropicmedicationsandpsychiatricdisorders " title="sec"> <div class="title" tagx="title" title="title">
Non-psychotropic medications and psychiatric disorders </div> <p> Several non-PMs influence the course of a psychiatric disorder in patients who do not suffer from the physical diseases for which these non-PMs are indicated. Drugs like β-blockers are known for their effect against anxiety, while others, like antibiotics (such as minocycline), are recent additions to the psychiatric field. In the list below, we focus on several molecules for which there is some evidence of efficacy (the development of non-PMs for neuropsychiatric clinical indications has the advantage for the pharmaceutical industry of a less costly drug development process). Some examples below might be new to some readers, while other non-PMs have been known to be prescribed in psychiatry for decades.  </p> </div> <div class="acetylsalicylicacidandothernonsteroidal anti-inflammatorydrugs " title="sec"> <div class="title" tagx="title" title="title">
Acetylsalicylic acid and other nonsteroidal  anti-inflammatory drugs </div> <p> There is evidence for a role of inflammation, oxidative and nitrosative stress, and mitochondrial dysfunction in disorders such as depression, schizophrenia, bipolar disorder, and AD. <sup> <a href="#ref1">1</a> </sup> Acetylsalicylic acid and other nonsteroidal anti-inflammatory drugs (NSAIDs) protect against oxidative damage, and have shown beneficial effects on mood disorders. <sup> <a href="#ref2">2</a> </sup> , <sup> <a href="#ref3">3</a> </sup> A moderate antidepressant effect was observed for adjuvant NSAIDs compared with conventional therapy alone in the treatment of bipolar depression. <sup> <a href="#ref4">4</a> </sup> A systematic review and meta-analysis of randomized clinical trials (RCTs) suggests that NSAIDs, in particular celecoxib, decrease depressive symptoms without increased risks of adverse effects. <sup> <a href="#ref5">5</a> </sup> Further trials are needed before making recommendations about the clinical use of anti-inflammatory drugs in the treatment of mood disorders. <sup> <a href="#ref6">6</a> </sup> Very preliminary clinical work also suggests some efficacy of acetylsalicylic acid in schizophrenia. <sup> <a href="#ref7">7</a> </sup>   </p> <p> Epidemiological data show that patients who take NSAIDs long-term are at lower risk of AD, and NSAIDs have generated enthusiasm for reducing the risk of AD. <sup> <a href="#ref8">8</a> </sup> However, clinical trials to date have shown no superiority over placebo for sulindac, piroxicam, acetaminophen, naproxen, nabumetone, ketoprofen, diclofenac, or acetylsalicylic acid. <sup> <a href="#ref9">9</a> </sup> The prescription of NSAIDs cannot be recommended for either prevention or treatment of AD.  </p> </div> <div class="bumetanide " title="sec"> <div class="title" tagx="title" title="title">
Bumetanide </div> <p> The diuretic bumetanide decreases intraneuronal chloride concentration and thereby facilitates γ-aminobutyric acid (GABA) inhibition. In animal models of ASD, bumetanide restores intraneuronal chloride levels, enhances GABAergic inhibition, and attenuates behavioral symptoms. In a phase II trial, bumetanide reduced the severity of ASD in children and adolescents. <sup> <a href="#ref10">10</a> </sup> A case report suggests that long-term treatment reduced hallucinations and that this treatment may also be useful to treat schizophrenia. <sup> <a href="#ref11">11</a> </sup> However, this was not confirmed in a later small double-blind study. <sup> <a href="#ref12">12</a> </sup>   </p> </div> <div class="clonidineandotherα-blockers " title="sec"> <div class="title" tagx="title" title="title">
Clonidine and other α-blockers </div> <p> The antihypertensive clonidine is a central α-2 agonist that also acts through imidazoline receptors. <sup> <a href="#ref13">13</a> </sup> Guanfacine has the same mode of action, but with less sedation. Both were approved as antihypertensives by the Food and Drug Administration (FDA) in 1974 and 1986. In 2010, they were registered for the treatment of attention-deficit hyperactivity disorder (ADHD) in a pediatric population (6 to 17 years). Both are listed in ADHD treatment guidelines. <sup> <a href="#ref14">14</a> </sup> They are also efficacious in opiate withdrawal, alcohol withdrawal, and smoking cessation, and have been studied in Tourette syndrome, with benefits on behavior and tics. <sup> <a href="#ref15">15</a> </sup> Clonidine is effective in smoking cessation. <sup> <a href="#ref16">16</a> </sup> It could also reduce traumatic memories and nightmares in patients with post-traumatic stress disorder (PTSD). A systematic review found slight but positive evidence for prazosin, an α-1 blocker, for the treatment of nightmares in PTSD. <sup> <a href="#ref17">17</a> </sup>   </p> </div> <div class="gabapentinandotheranticonvulsants " title="sec"> <div class="title" tagx="title" title="title">
Gabapentin and other anticonvulsants </div> <p> The antiepileptics valproic acid, lamotrigine, and carbamazepine have a recognized role in psychiatry that will not be commented on here. Gabapentin inhibits the α2δ subunit of voltage-dependent calcium channels. It is indicated for neuralgias, restless leg syndrome, and partial seizures. It has shown efficacy in alcohol craving, alcohol withdrawal, and several anxiety disorders including social anxiety. <sup> <a href="#ref18">18</a> </sup> Its close compound pregabalin has been registered in the United States for use in social anxiety, fibromyalgia, and generalized anxiety.  </p> </div> <div class="hydroxyzineandotherantihistamines " title="sec"> <div class="title" tagx="title" title="title">
Hydroxyzine and other antihistamines </div> <p> The first antihistamines used against allergic conditions are antagonists to the histamine H1 receptor, which have also long been prescribed as sleeping pills; diphenhydramine and several other antihistamines have been registered in many countries as over the counter (OTC) sleeping pills. <sup> <a href="#ref19">19</a> </sup> Hydroxyzine was registered by the FDA a long time ago, in 1956, for the symptomatic relief of anxiety; the results are considered equivalent to those of other anxiolytics such as benzodiazepines in terms of efficacy, acceptability, and tolerability, but this indication is recommended by only a few authors. <sup> <a href="#ref20">20</a> </sup> Hydroxyzine, like other early antihistamines, has anticholinergic and antidopaminergic effects that participate in the side effect profile. The more recent H1-blockers such as cetirizine or loratadine have not been studied as sleeping pills, although cetirizine induces some sedation. Pitolisant, an antagonist to the H3 receptor, has been registered in several countries to treat narcolepsy. The H3 receptors being presynaptic, their blockade leads to more histamine and other neurotransmitters being released, and pitolisant and other H3 antagonists are being studied as nootropic agents.  </p> </div> <div class="ketamineandotherglutamatergicantagonists " title="sec"> <div class="title" tagx="title" title="title">
Ketamine and other glutamatergic antagonists </div> <p> Ketamine is a nonselective NMDA glutamatergic receptor antagonist. While GABA serves as the main site-to-site (ie, with rather short axons) inhibitory transmitter, glutamate is the main excitatory site-to-site one, with too much glutamate release leading to neurotoxicity. Ketamine is used in anesthesia and for the management of post-surgery pain. Several randomized controlled trials (RCTs) of intravenous ketamine provide findings of efficacy in treatment-resistant depression, bipolar depression, and suicidal ideation. <sup> <a href="#ref21">21</a> </sup> Intranasal esketamine, the S enantiomer of ketamine, was accepted in early 2019 by the FDA for treatment-resistant depression. <sup> <a href="#ref22">22</a> </sup> Amantadine, a weak NMDA receptor antagonist with antiviral properties, can play a role alone or in association with cholinesterase inhibitors to enhance cognitive function and reduce behavioral symptoms in AD. <sup> <a href="#ref23">23</a> </sup>   </p> </div> <div class="minocyclineandotherantibiotics " title="sec"> <div class="title" tagx="title" title="title">
Minocycline and other antibiotics </div> <p> Minocycline is a tetracycline bacteriostatic antibiotic. Apart from its antibacterial properties, minocycline has anti-inflammatory, antiapoptotic, and neuroprotective effects. <sup> <a href="#ref24">24</a> </sup> Minocycline might be useful in major depressive disorder (MDD) and in bipolar depression. <sup> <a href="#ref25">25</a> </sup> - <sup> <a href="#ref27">27</a> </sup> A link between high level of Il-6 or brain glutathione and a better response to minocycline is supposed. The clinical effects of adjunctive minocycline on the negative symptoms of schizophrenia are controversial, <sup> <a href="#ref28">28</a> </sup> , <sup> <a href="#ref29">29</a> </sup> although a recent meta-analysis shows positive results. <sup> <a href="#ref30">30</a> </sup>   </p> <p> Rifampicin inhibits bacterial RNA polymerase. It inhibits the formation of amyloid-β, tau protein and α-synuclein, with promising results in animal models of AD. <sup> <a href="#ref31">31</a> </sup> , <sup> <a href="#ref32">32</a> </sup> The progression of AD might be slowed with rifampicin associated with doxycycline or rifampicin alone. <sup> <a href="#ref33">33</a> </sup> , <sup> <a href="#ref34">34</a> </sup> These results were not confirmed in other trials, maybe because of dose and length of treatment issues. <sup> <a href="#ref35">35</a> </sup> , <sup> <a href="#ref36">36</a> </sup>   </p> </div> <div class="n-acetylcysteineandover-the-counterdrugs " title="sec"> <div class="title" tagx="title" title="title">
N-Acetylcysteine and over-the-counter drugs </div> <p> N-acetylcysteine (NAC) is prescribed for its mucolytic effects and as antidote in cases of acetaminophen overdose by providing a precursor for the glutathione synthetase pathway. <sup> <a href="#ref37">37</a> </sup> The rationale for studying NAC in psychiatry is based on its interference with several signaling pathways that play a role in regulating apoptosis, angiogenesis, cell growth and inflammatory pathways, as well as on its modulatory action on glutamatergic and dopaminergic systems. <sup> <a href="#ref38">38</a> </sup> The efficacy of NAC was discussed in an extensive review which considers an astonishingly long list of psychiatric disorders, with the conclusion that no firm recommendation could be given yet for NAC in any indication. <sup> <a href="#ref39">39</a> </sup> The highest evidence, (at least one prospective high-quality RCT) were found for dependency treatment (cannabis, cocaine, and nicotine), unipolar and bipolar depression, schizophrenia, and trichotillomania. According to a 2018 meta-analysis, adjunctive NAC has efficacy in schizophrenia, but not in mood disorders or major depressive disorder. <sup> <a href="#ref40">40</a> </sup> Further high-quality RCTs are warranted to determine the role of adjunctive NAC in the treatment of major psychiatric disorders.  </p> <p> S-adenosyl-L-methionine (SAMe), sold as a dietary supplement in United States and Canada, is an endogenous, intracellular amino acid metabolite involved in multiple crucial biochemical pathways, including biosynthesis of hormones and neurotransmitters. During the 1970s and 1980s, SAMe was studied after intravenous administration. A review of SAMe in major depression found limited evidence of efficacy to support its use as a monotherapy or as augmentation with other antidepressants; the authors were optimistic, but recognized that studies were of insufficient methodological quality. <sup> <a href="#ref41">41</a> </sup>   </p> <p> Tryptophan and hydroxytryptophan (5-HTP), amino acids that are precursors of serotonin, are sometimes called natural alternatives to traditional antidepressants, but they are less effective and safety concerns have not been clarified. <sup> <a href="#ref42">42</a> </sup>   </p> </div> <div class="pramipexoleandotherantiparkinsoniandrugs " title="sec"> <div class="title" tagx="title" title="title">
Pramipexole and other antiparkinsonian drugs </div> <p> Pramipexole is a dopamine D2 and D3 receptor agonist indicated in Parkinson disease (PD) and restless legs syndrome. Pramipexole is effective in unipolar and bipolar depression in association with antidepressants or mood stabilizers. <sup> <a href="#ref43">43</a> </sup> It has also been studied in monotherapy with results comparable to fluoxetine, but with side effects at high doses. <sup> <a href="#ref44">44</a> </sup> Most data concern its use as augmentation treatment for which low or moderate doses up to 1.5 mg are sufficient with good safety concerns. The rate of manic or hypomanic switch is also very low and pramipexole is quoted as an option for bipolar depression in guidelines. <sup> <a href="#ref45">45</a> </sup> In drug-resistant depression, it is an alternative to other treatments (lithium, aripiprazole, or quetiapine) with easier use and fewer side effects.  </p> <p> Other antiparkinsonian drugs, such as ropinirole, pergolide, and bromocriptine, have been less extensively studied in depression. Very anecdotally, in a small case series dating back 50 years, delusional depression responded to L-dopa, while nowadays delusion would be a contraindication to dopamine agonists. <sup> <a href="#ref46">46</a> </sup>   </p> </div> <div class="propranololandotherβ-blockers " title="sec"> <div class="title" tagx="title" title="title">
Propranolol and other β-blockers </div> <p> These cardiovascular medications reduce sympathetic nervous system activity by blocking β-adrenergic receptors. Lipophilic β-blockers pass the blood-brain barrier, which is the case with propranolol. <sup> <a href="#ref47">47</a> </sup> , <sup> <a href="#ref48">48</a> </sup> Aside from cardiovascular indications, migraine, and essential tremor, propranolol might be useful in panic attacks. <sup> <a href="#ref49">49</a> </sup> Also, a meta-analysis showed no difference between propranolol and benzodiazepines on anxiety, panic attack frequency, and avoidance behavior, although equivalence was not proven. <sup> <a href="#ref50">50</a> </sup> Several studies showed that propranolol decreased apprehension before diagnostic tests or dental interventions and some clinicians prescribe it to persons in stressing situations, like exams, playing music, or acting, with the benefit of no sedation. Since β-blockers inhibit memory consolidation, propranolol has been studied in PTSD prevention. <sup> <a href="#ref51">51</a> </sup> - <sup> <a href="#ref53">53</a> </sup> Studies on how soon it should be administered after a trauma are ongoing. A recent RCT concluded that propranolol associated with brief memory reactivation had significant results compared with placebo in the treatment of PTSD. <sup> <a href="#ref54">54</a> </sup>   </p> </div> <div class="statins " title="sec"> <div class="title" tagx="title" title="title">
Statins </div> <p> Statins, which act as hydroxylmethyl glutaryl coenzyme A reductase inhibitors, have been studied in patients with schizophrenia. A meta-analysis of 6 RCT, totalizing 169 patients using statins as adjunctive therapy, found a significant improvement for negative and positive symptoms. <sup> <a href="#ref55">55</a> </sup> Hypotheses underlying these effects concern anti-inflammatory properties, interactions with P-glycoprotein substrates, or neuroprotective effects through N-methyl-D-aspartate receptor upregulation and increase of muscarinic receptor binding. In a large observational study, a reduction of self-harm has been observed. The authors checked the files of 142 691 patients diagnosed with bipolar disorder, schizophrenia, or nonaffective psychosis, and found a reduction in psychiatric hospitalization rates in patients receiving statins, L-type calcium channel antagonists or biguanides such as metformin. <sup> <a href="#ref56">56</a> </sup>   </p> </div> <div class="thyroidhormones " title="sec"> <div class="title" tagx="title" title="title">
Thyroid hormones </div> <p> While there is no evidence that triiodothyronine (T3) alone is a useful antidepressant, it is recommended as adjunctive medication for the treatment of resistant depression. <sup> <a href="#ref57">57</a> </sup> , <sup> <a href="#ref58">58</a> </sup> Evidence for its efficacy comes mainly from its association with tricyclic antidepressants or selective serotonin reuptake inhibitors (SSRIs). <sup> <a href="#ref59">59</a> </sup> Using thyroid hormones in bipolar depression is also being discussed, but with less evidence. <sup> <a href="#ref60">60</a> </sup>   </p> </div> <div class="outlookandconclusions " title="sec"> <div class="title" tagx="title" title="title">
Outlook and conclusions </div> <p> The prescription of non-PMs in psychiatric disorders indicates that the future of psychiatric treatment is not based solely on PMs. When favorable results with a non-PM in a purely psychiatric indication are confirmed, the non-PM, after a period of off-label use, is included in official guidelines <i>(Table I)</i> and eventually registered by the FDA or other agencies. Each guideline uses its own evaluation of evidence with less or more requirements. Usually, level 1 evidence corresponds to high-quality meta-analysis, level 2 to high-quality double-blind RCT, level 3 to other studies, and level 4 to expert opinions.  </p> <p> The hormone T3 is recommended as a second-line adjunctive medication in treatment-resistant depression with a level 2 evidence while there already is level 1 evidence for ketamine perfusion which was still considered as experimental in some guidelines for depression. <sup> <a href="#ref58">58</a> </sup> Pramipexole, intravenous ketamine, NAC, and T3 are considered as third-line adjunctive treatment in bipolar depression, with level 3 evidence. <sup> <a href="#ref45">45</a> </sup> It is noteworthy to underline that a low level of evidence, such as a level 3, does not necessarily mean lower efficacy or less tolerability, but can also highlight a lack of studies, in number and in quality. It is the case of gabapentin which is listed as first-line treatment in anxiety symptoms among bipolar patients, despite only level 3 evidence. <sup> <a href="#ref61">61</a> </sup> The β-blocker propranolol is not recommended in anxiety guidelines, because available data overall is against it for now. <sup> <a href="#ref62">62</a> </sup> Propranolol has been evaluated in many studies that do not reach expected quality level; there are few RCTs and most of them concern panic attacks and agoraphobia, for which a meta-analysis was not conclusive. <sup> <a href="#ref39">39</a> </sup>   </p> <p> Evidence-based medicine is intrinsically limited by availability of data. The example of lithium as a first choice in bipolar disorder is illustrative since this undisputed reference drug for bipolar disorder only has level 2 evidence in bipolar depression. Tamoxifen has level 2 evidence for treating acute mania, but with safety concerns and little clinical experience <sup> <a href="#ref63">63</a> </sup> ; therefore, contrarily to lithium, it cannot be advised as first-line treatment. Concerning NSAIDs, a meta-analysis found positive results in depression, which would correspond at least to level 2 evidence; however, there are limitations due to the possibility of bias and to the heterogeneity of available studies. Moreover, the use of NSAIDs in psychiatry needs an extensive appreciation of safety concerns, notably about infectious risk. <sup> <a href="#ref64">64</a> </sup>   </p> <p> Guidelines are a good summary of what is rather well established at a given moment. But there are delays between the discovery of potential beneficial effects of a molecule in a neuropsychiatric disorder and their validation with the inclusion of the molecule in guidelines. Indeed, it takes time to finance and then perform quality studies, the results of which finally get included into guidelines. So-called preliminary data can sometimes remain a long time without confirmation, either positive or negative. So, with several non-PMs, such as bumetanide, minocycline, and rifampicin, as well as NSAIDs and SAMe, further trials are needed to establish their usefulness in psychiatric treatment.  </p> <p> These delays can be acceptable when other effective medications are available, but they can be distressing to patients and therapists for disorders with no known treatment. Considering the case of AD, current guidelines recommend at least a try with cholinesterase inhibitors or NMDA antagonists, since there is no better alternative. <sup> <a href="#ref65">65</a> </sup> This encourages exploration of new drugs and it will be important to establish how much NSAIDs, rifampicin, or doxycycline really protect from AD or slow its evolution. The same is true for preventing the development of PTSD, with very few data available except rare but encouraging results for propranolol and hydrocortisone, which administered shortly after a trauma, favorably influence memory retrieval. <sup> <a href="#ref66">66</a> </sup> , <sup> <a href="#ref67">67</a> </sup> Propranolol, (but not hydrocortisone), has been listed in a guideline as an option to prevent the emergence of post-traumatic symptoms. <sup> <a href="#ref68">68</a> </sup>   </p> <p> While the primary focus of our review is on the potential role of several non-PMs on the evolution of psychiatric disorders, there are two other issues pertaining to the relevance of medical treatments to psychiatry, first, the improvement of psychiatric symptoms by treating non-psychiatric diseases, and, second, the prevention of neuropsychiatric syndromes by treating or preventing non-psychiatric diseases. Unfortunately, there are very few studies aimed at these clinically relevant questions.  </p> <p> As for the first issue, many physical diseases or disorders such as auto-immune diseases (lupus erythematosus, autoimmune encephalitis, etc), endocrine diseases, Parkinson disease and other neurological diseases, intoxications, metabolic diseases, infections, fever, dehydration, and many other situations induce psychiatric symptoms. Depending on their severity, these situations could be treated without PMs, ie, by improving the physical condition. Trials comparing psychiatric outcomes in non-PM groups with non-PM plus PM groups are lacking.  </p> <p> As to the second issue, which is relevant to psychiatric epidemiology, the question raised is whether treatment or prevention of given non-psychiatric diseases might delay or suppress the occurrence of neuropsychiatric syndromes: how do early interventions delay or prevent the physical disease and how could this prevent psychiatric complications? Examples are that the early detection of hypertension may reduce dementia prevalence. <sup> <a href="#ref69">69</a> </sup> - <sup> <a href="#ref71">71</a> </sup> Cardiovascular prevention based on known risk factors has potential beneficial effects on the incidence of psychiatric disorders. An epidemiological study did show a reduction of psychiatric hospitalization among patients receiving statins, L-type calcium channel antagonists, or biguanides. <sup> <a href="#ref56">56</a> </sup> But a causal link cannot be asserted. Were the findings a direct or indirect effect of the non-PMs on the psychiatric disorders? Do these non-PMs have clear psychotropic properties? And if so, what are these properties? Psychiatric patients often receive less care than they should; so, by receiving cardiovascular treatments, were these patients more exposed to also receiving treatment for psychiatric symptoms? There are also questions about the association between cardiovascular and psychiatric disorders and about how treating one may affect the other. Diabetes mellitus is highly associated with depression. <sup> <a href="#ref72">72</a> </sup> If untreated, it leads to cardiovascular complications, themselves associated with mood disorders or dementia. Obesity, the major risk factor for cardiovascular disorders, and a source of stigmatization among young people, shows a reciprocal link with depression. <sup> <a href="#ref73">73</a> </sup> , <sup> <a href="#ref74">74</a> </sup> Vaccination is among the best illustrations of how psychiatric symptoms can be prevented by internal medicine interventions. Vaccines protect against many infections that affect brain functions: tick-borne diseases, viral encephalitis, etc. In some cases, the relation between psychiatric disorders and nonpsychiatric diseases is reciprocal. For example, treatment of tobacco addiction decreases the prevalence of COPD, and a reduced prevalence of this severe physical disease lessens its psychiatric complications, notably depression.  </p> <p> We reviewed several non-PMs that already have or that could have a role in the practice of psychiatry. There is sufficient evidence for some non-PMs to be recommended in psychiatric guidelines, indicating that the pharmacological treatment of psychiatric disorders does not only rely on PMs. However, the lack of high-quality data remains the main issue for most of the indications of non-PMs in neuropsychiatric disorders.  </p> <p> <div class="table-wrap_UNKNOWN" orientation="portrait" id="d35e529" position="float"> </div></p><table frame="hsides" rules="groups"> <thead> <tr> <td rowspan="1" colspan="1"> Drug  </td> <td rowspan="1" colspan="1"> Drug class  </td> <td rowspan="1" colspan="1"> Official  indication </td> <td rowspan="1" colspan="1"> Psychiatric  disorder </td> <td rowspan="1" colspan="1"> Recommendation  in psychiatry* </td> </tr> </thead> <tbody> <tr> <td rowspan="1" colspan="1"> 5-HTP </td> <td rowspan="1" colspan="1"> Amino acid </td> <td rowspan="1" colspan="1"> None </td> <td rowspan="1" colspan="1"> Depression </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> Amantadine </td> <td rowspan="1" colspan="1"> NMDA receptor  antagonist </td> <td rowspan="1" colspan="1"> Parkinsonian symptoms, influenza treatment and prophylaxis </td> <td rowspan="1" colspan="1"> Alzheimer disease </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> Bumetanide </td> <td rowspan="1" colspan="1"> Loop diuretic </td> <td rowspan="1" colspan="1"> Swelling </td> <td rowspan="1" colspan="1"> Autism spectrum disorders, schizophrenia </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> Clonidine </td> <td rowspan="1" colspan="1"> Central  a-2 agonist </td> <td rowspan="1" colspan="1"> High blood pressure, cancer pain, ADHD in pediatric population </td> <td rowspan="1" colspan="1"> ADHD Smoking cessation </td> <td rowspan="1" colspan="1"> Recommended in ADHD if no response to other treatments and after advice from tertiary ADHD service14  Recommended as second- line treatment in smoking cessation16 </td> </tr> <tr> <td rowspan="1" colspan="1"> Gabapentine </td> <td rowspan="1" colspan="1"> Agonist GABA </td> <td rowspan="1" colspan="1"> Epilepsy, neuropathic pain </td> <td rowspan="1" colspan="1"> Anxiety disorder,  bipolar disorder </td> <td rowspan="1" colspan="1"> Yes as third-line treatment in panic disorder, second-line in social anxiety disorder, and third-line adjunctive therapy in PTSD62  As first-line treatment in anxiety disorders associated with bipolar disorder61  In maintenance therapy in  bipolar disorder45 </td> </tr> <tr> <td rowspan="1" colspan="1"> Guanfacine </td> <td rowspan="1" colspan="1"> Central  a-2 agonist </td> <td rowspan="1" colspan="1"> High blood pressure, ADHD in pediatric population </td> <td rowspan="1" colspan="1"> ADHD </td> <td rowspan="1" colspan="1"> Recommended if no response to other treatments and after advice from tertiary ADHD service14 </td> </tr> <tr> <td rowspan="1" colspan="1"> Ketamine in  perfusion** </td> <td rowspan="1" colspan="1"> NMDA receptor antagonist </td> <td rowspan="1" colspan="1"> Anesthesia </td> <td rowspan="1" colspan="1"> Unipolar and bipolar  depression </td> <td rowspan="1" colspan="1"> As third-line adjunctive treatment in bipolar depression45 </td> </tr> <tr> <td rowspan="1" colspan="1"> Minocycline </td> <td rowspan="1" colspan="1"> Antibiotics </td> <td rowspan="1" colspan="1"> Infections, acne </td> <td rowspan="1" colspan="1"> Depression </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> NAC </td> <td rowspan="1" colspan="1"> Amino acid </td> <td rowspan="1" colspan="1"> Mucous secretions in broncho-pulmonary disorders, antidote for paracetamol overdose </td> <td rowspan="1" colspan="1"> Unipolar and bipolar depression,  schizophrenia </td> <td rowspan="1" colspan="1"> As third-line adjunctive  treatment in bipolar  depression45 </td> </tr> <tr> <td rowspan="1" colspan="1"> NSAIDs </td> <td rowspan="1" colspan="1"> Anti-inflammatory </td> <td rowspan="1" colspan="1"> Pain, fever </td> <td rowspan="1" colspan="1"> Mood disorders </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> Acetylsalicylic acid </td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1"> Cardiovascular  prophylaxis </td> <td rowspan="1" colspan="1"> Schizophrenia Depression </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> Pramipexole </td> <td rowspan="1" colspan="1"> Antiparkinsonian </td> <td rowspan="1" colspan="1"> Parkinsonian symptoms, restless legs syndrome </td> <td rowspan="1" colspan="1"> Unipolar and bipolar depression </td> <td rowspan="1" colspan="1"> As third-line adjunctive treatment in bipolar depression45 </td> </tr> <tr> <td rowspan="1" colspan="1"> Propranolol </td> <td rowspan="1" colspan="1"> β-blockers </td> <td rowspan="1" colspan="1"> High blood pressure, angina pectoris, atrial fibrillation, migraine, essential tremor </td> <td rowspan="1" colspan="1"> Anxiety disorders, PTSD prevention </td> <td rowspan="1" colspan="1"> Not recommended in GAD, SAD, or PD62 Can be discussed in  prevention of post-traumatic symptoms68 </td> </tr> <tr> <td rowspan="1" colspan="1"> Rifampicin </td> <td rowspan="1" colspan="1"> Antibiotics </td> <td rowspan="1" colspan="1"> Infections </td> <td rowspan="1" colspan="1"> Depression </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> S-adenosyl-L methionine </td> <td rowspan="1" colspan="1"> Substrate in  different metabolic reactions </td> <td rowspan="1" colspan="1"> None </td> <td rowspan="1" colspan="1"> Depression </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> Statins </td> <td rowspan="1" colspan="1"> Hypolipidemic drugs </td> <td rowspan="1" colspan="1"> Hypercholesterolemia, hypertriglyceridemia </td> <td rowspan="1" colspan="1"> Schizophrenia </td> <td rowspan="1" colspan="1" /> </tr> <tr> <td rowspan="1" colspan="1"> Tamoxifen </td> <td rowspan="1" colspan="1"> Chemotherapy </td> <td rowspan="1" colspan="1"> Breast cancer </td> <td rowspan="1" colspan="1"> Acute mania </td> <td rowspan="1" colspan="1"> As third-line treatment in acute mania45 </td> </tr> <tr> <td rowspan="1" colspan="1"> T3 </td> <td rowspan="1" colspan="1"> Thyroid hormone </td> <td rowspan="1" colspan="1"> Hypothyroidism </td> <td rowspan="1" colspan="1"> Unipolar and bipolar depression </td> <td rowspan="1" colspan="1"> As second-line adjunctive  medication in treatment  resistant depression58 As third-line adjunctive treatment in bipolar depression45 </td> </tr> </tbody> </table>  <p /> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <p>The authors have no conflicts of interest.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
REFERENCES</div> <li tag="ref"> <a name="ref1" /> <span class="label" tagx="label" title="label">1</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Berk</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Dean</span> <span class="given-names" tagx="given-names" title="given-names">O,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Drexhage</span> <span class="given-names" tagx="given-names" title="given-names">H,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. </span> <span class="source" tagx="source" title="source"> <i>BMC Med.</i> </span> <span class="year" tagx="year" title="year">2013</span> <span class="fpage" tagx="fpage" title="fpage">11</span> <span class="lpage" tagx="lpage" title="lpage">74</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/23324495">23324495</a> </span> </span> </li> <li tag="ref"> <a name="ref2" /> <span class="label" tagx="label" title="label">2</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mendlewicz</span> <span class="given-names" tagx="given-names" title="given-names">J,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kriwin</span> <span class="given-names" tagx="given-names" title="given-names">P,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Oswald</span> <span class="given-names" tagx="given-names" title="given-names">P,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Souery </span> <span class="given-names" tagx="given-names" title="given-names">D,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Alboni</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Brunello</span> <span class="given-names" tagx="given-names" title="given-names">N.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. </span> <span class="source" tagx="source" title="source"> <i>Int Clin Psychopharmacol.</i> </span> <span class="year" tagx="year" title="year">2006</span> <span class="volume" tagx="volume" title="volume">21</span> <span class="issue" tagx="issue" title="issue">4</span> <span class="fpage" tagx="fpage" title="fpage">227231</span> </span> </li> <li tag="ref"> <a name="ref3" /> <span class="label" tagx="label" title="label">3</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Savitz</span> <span class="given-names" tagx="given-names" title="given-names">J,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Preskorn</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Teague</span> <span class="given-names" tagx="given-names" title="given-names">TK,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Drevets</span> <span class="given-names" tagx="given-names" title="given-names">D,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Yates</span> <span class="given-names" tagx="given-names" title="given-names">W,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Drevets</span> <span class="given-names" tagx="given-names" title="given-names">W.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial. </span> <span class="source" tagx="source" title="source"> <i>BMJ Open.</i> </span> <span class="year" tagx="year" title="year">2012</span> <span class="volume" tagx="volume" title="volume">2</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">e000643</span> <span class="pub-id"> <a href="https://dx.doi.org/10.1136/bmjopen-2011-000643.">10.1136/bmjopen-2011-000643.</a> </span> </span> </li> <li tag="ref"> <a name="ref4" /> <span class="label" tagx="label" title="label">4</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rosenblat</span> <span class="given-names" tagx="given-names" title="given-names">JD,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kakar</span> <span class="given-names" tagx="given-names" title="given-names">R,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Berk</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. </span> <span class="source" tagx="source" title="source"> <i>Bipolar Disord.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">18</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">89</span> <span class="lpage" tagx="lpage" title="lpage">101</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/26990051">26990051</a> </span> </span> </li> <li tag="ref"> <a name="ref5" /> <span class="label" tagx="label" title="label">5</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Köhler</span> <span class="given-names" tagx="given-names" title="given-names">O,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Benros</span> <span class="given-names" tagx="given-names" title="given-names">ME,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Nordentoft</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. 71 </span> <span class="source" tagx="source" title="source"> <i>JAMA Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2014</span> <span class="issue" tagx="issue" title="issue">12</span> <span class="fpage" tagx="fpage" title="fpage">1381</span> <span class="lpage" tagx="lpage" title="lpage">1391</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25322082">25322082</a> </span> </span> </li> <li tag="ref"> <a name="ref6" /> <span class="label" tagx="label" title="label">6</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Husain</span> <span class="given-names" tagx="given-names" title="given-names">MI,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Strawbridge</span> <span class="given-names" tagx="given-names" title="given-names">R,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Stokes</span> <span class="given-names" tagx="given-names" title="given-names">PR,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Young</span> <span class="given-names" tagx="given-names" title="given-names">AH.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis. </span> <span class="source" tagx="source" title="source"> <i>J Psychopharmacol.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">31</span> <span class="issue" tagx="issue" title="issue">9</span> <span class="fpage" tagx="fpage" title="fpage">11371148</span> </span> </li> <li tag="ref"> <a name="ref7" /> <span class="label" tagx="label" title="label">7</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Laan</span> <span class="given-names" tagx="given-names" title="given-names">W,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Grobbee</span> <span class="given-names" tagx="given-names" title="given-names">DE,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Selten</span> <span class="given-names" tagx="given-names" title="given-names">JP,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Heijnen</span> <span class="given-names" tagx="given-names" title="given-names">CJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kahn</span> <span class="given-names" tagx="given-names" title="given-names">RS,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Burger</span> <span class="given-names" tagx="given-names" title="given-names">H.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. </span> <span class="source" tagx="source" title="source"> <i>J Clin Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2010</span> <span class="volume" tagx="volume" title="volume">71</span> <span class="issue" tagx="issue" title="issue">5</span> <span class="fpage" tagx="fpage" title="fpage">520527</span> </span> </li> <li tag="ref"> <a name="ref8" /> <span class="label" tagx="label" title="label">8</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Deardorff</span> <span class="given-names" tagx="given-names" title="given-names">WJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Grossberg</span> <span class="given-names" tagx="given-names" title="given-names">GT.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics. </span> <span class="source" tagx="source" title="source"> <i>Exp Rev Neurother.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">17</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">1732</span> </span> </li> <li tag="ref"> <a name="ref9" /> <span class="label" tagx="label" title="label">9</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Nevado-Holgado</span> <span class="given-names" tagx="given-names" title="given-names">AJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lovestone</span> <span class="given-names" tagx="given-names" title="given-names">S.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer’s disease: A bioinformatics approach. </span> <span class="source" tagx="source" title="source"> <i>Comput Struct Biotechnol J.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">15</span> <span class="fpage" tagx="fpage" title="fpage">1</span> <span class="lpage" tagx="lpage" title="lpage">7</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27872687">27872687</a> </span> </span> </li> <li tag="ref"> <a name="ref10" /> <span class="label" tagx="label" title="label">10</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lemonnier</span> <span class="given-names" tagx="given-names" title="given-names">E,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Villeneuve</span> <span class="given-names" tagx="given-names" title="given-names">N,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sonie</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders. </span> <span class="source" tagx="source" title="source"> <i>Transl Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">7</span> <span class="issue" tagx="issue" title="issue">3</span> <span class="fpage" tagx="fpage" title="fpage">e1056</span> <span class="pub-id"> <a href="https://dx.doi.org/10.1038/tp.2017.10.">10.1038/tp.2017.10.</a> </span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/28291262">28291262</a> </span> </span> </li> <li tag="ref"> <a name="ref11" /> <span class="label" tagx="label" title="label">11</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lemonnier</span> <span class="given-names" tagx="given-names" title="given-names">E,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lazartigues</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ben-Ari</span> <span class="given-names" tagx="given-names" title="given-names">Y.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Treating schizophrenia with the diuretic bumetanide: a case report. </span> <span class="source" tagx="source" title="source"> <i>Clin Neuropharmacol.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">39</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">115</span> <span class="lpage" tagx="lpage" title="lpage">117</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/26966887">26966887</a> </span> </span> </li> <li tag="ref"> <a name="ref12" /> <span class="label" tagx="label" title="label">12</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rahmanzadeh</span> <span class="given-names" tagx="given-names" title="given-names">R,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Shahbazi</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ardakani</span> <span class="given-names" tagx="given-names" title="given-names">MK,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mehrabi</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rahmanzade</span> <span class="given-names" tagx="given-names" title="given-names">R,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Joghateaei</span> <span class="given-names" tagx="given-names" title="given-names">MT.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Lack of the effect of bumetanide, a selective NKCC1 inhibitor, in patients with schizophrenia: a double-blind randomized trial. </span> <span class="source" tagx="source" title="source"> <i>Psychiatry Clin Neurosci.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">71</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">72</span> <span class="lpage" tagx="lpage" title="lpage">73</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27800670">27800670</a> </span> </span> </li> <li tag="ref"> <a name="ref13" /> <span class="label" tagx="label" title="label">13</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lowry</span> <span class="given-names" tagx="given-names" title="given-names">JA,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Brown</span> <span class="given-names" tagx="given-names" title="given-names">JT.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Significance of the imidazoline receptors in toxicology. </span> <span class="source" tagx="source" title="source"> <i>Clin Toxicol (Phila).</i> </span> <span class="year" tagx="year" title="year">2014 Jun</span> <span class="volume" tagx="volume" title="volume">52</span> <span class="issue" tagx="issue" title="issue">5</span> <span class="fpage" tagx="fpage" title="fpage">454</span> <span class="lpage" tagx="lpage" title="lpage">69</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/24666288">24666288</a> </span> </span> </li> <li tag="ref"> <a name="ref14" /> <span class="label" tagx="label" title="label">14</span> <span class="element-citation'"> <span class="mixed-article-title" title="mixed-article-title">Attention deficit hyperactivity disorder : diagnosis and management. </span> <span class="source" tagx="source" title="source"> <i /> </span> <span class="comment">Available at :</span> </span> </li> <li tag="ref"> <a name="ref15" /> <span class="label" tagx="label" title="label">15</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Naguy</span> <span class="given-names" tagx="given-names" title="given-names">A.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Clonidine use in psychiatry: panacea or panache.</span> <span class="source" tagx="source" title="source"> <i>Pharmacology.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">98</span> <span class="issue" tagx="issue" title="issue">1-2</span> <span class="fpage" tagx="fpage" title="fpage">87</span> <span class="lpage" tagx="lpage" title="lpage">92</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27161101">27161101</a> </span> </span> </li> <li tag="ref"> <a name="ref16" /> <span class="label" tagx="label" title="label">16</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Fiore</span> <span class="given-names" tagx="given-names" title="given-names">MC,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Jaén</span> <span class="given-names" tagx="given-names" title="given-names">CR,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Baker</span> <span class="given-names" tagx="given-names" title="given-names">TB,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Treating tobacco use and dependence: 2008 update.</span> <span class="source" tagx="source" title="source"> <i>Clinical Practice Guideline.</i> </span> <span class="year" tagx="year" title="year">2008</span> </span> </li> <li tag="ref"> <a name="ref17" /> <span class="label" tagx="label" title="label">17</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kung</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Espinel</span> <span class="given-names" tagx="given-names" title="given-names">Z,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lapid</span> <span class="given-names" tagx="given-names" title="given-names">MI.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Treatment of nightmares with prazosin: a systematic review. </span> <span class="source" tagx="source" title="source"> <i>Mayo Clin Proc.</i> </span> <span class="year" tagx="year" title="year">2012</span> <span class="volume" tagx="volume" title="volume">87</span> <span class="issue" tagx="issue" title="issue">9</span> <span class="fpage" tagx="fpage" title="fpage">890</span> <span class="lpage" tagx="lpage" title="lpage">900</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/22883741">22883741</a> </span> </span> </li> <li tag="ref"> <a name="ref18" /> <span class="label" tagx="label" title="label">18</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Berlin</span> <span class="given-names" tagx="given-names" title="given-names">RK,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Butler</span> <span class="given-names" tagx="given-names" title="given-names">PM,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Perloff</span> <span class="given-names" tagx="given-names" title="given-names">MD.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Gabapentin therapy in psychiatric disorders: a systematic review. </span> <span class="source" tagx="source" title="source"> <i>Prim Care Companion CNS Disord.</i> </span> <span class="year" tagx="year" title="year">2015</span> <span class="volume" tagx="volume" title="volume">17</span> <span class="issue" tagx="issue" title="issue">5</span> <span class="fpage" tagx="fpage" title="fpage">10.4088/PCC.15r01821</span> <span class="pub-id"> <a href="https://dx.doi.org/10.4088/PCC.15r01821.">10.4088/PCC.15r01821.</a> </span> </span> </li> <li tag="ref"> <a name="ref19" /> <span class="label" tagx="label" title="label">19</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Culpepper</span> <span class="given-names" tagx="given-names" title="given-names">L,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Wingertzahn</span> <span class="given-names" tagx="given-names" title="given-names">MA.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Over-the-counter agents for the treatment of occasional disturbed sleep or transient insomnia: a systematic review of efficacy and safety. </span> <span class="source" tagx="source" title="source"> <i>Prim Care Companion CNS Disord.</i> </span> <span class="year" tagx="year" title="year">2015</span> <span class="volume" tagx="volume" title="volume">17</span> <span class="issue" tagx="issue" title="issue">6</span> <span class="fpage" tagx="fpage" title="fpage">10.4088</span> <span class="lpage" tagx="lpage" title="lpage">PCC.15r01798</span> <span class="pub-id"> <a href="https://dx.doi.org/10.4088/PCC.15r01798">10.4088/PCC.15r01798</a> </span> </span> </li> <li tag="ref"> <a name="ref20" /> <span class="label" tagx="label" title="label">20</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Guaiana</span> <span class="given-names" tagx="given-names" title="given-names">G,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Barbui</span> <span class="given-names" tagx="given-names" title="given-names">C,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cipriani</span> <span class="given-names" tagx="given-names" title="given-names">A.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Hydroxyzine for generalised anxiety disorder.</span> <span class="source" tagx="source" title="source"> <i>Cochrane Database Syst Rev.</i> </span> <span class="year" tagx="year" title="year">2010</span> <span class="volume" tagx="volume" title="volume">12</span> <span class="fpage" tagx="fpage" title="fpage">CD006815</span> <span class="pub-id"> <a href="https://dx.doi.org/10.1002/14651858.CD006815.pub2">10.1002/14651858.CD006815.pub2</a> </span> </span> </li> <li tag="ref"> <a name="ref21" /> <span class="label" tagx="label" title="label">21</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Iadarola</span> <span class="given-names" tagx="given-names" title="given-names">ND,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Niciu</span> <span class="given-names" tagx="given-names" title="given-names">MJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Richards</span> <span class="given-names" tagx="given-names" title="given-names">EM,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Ketamine and other N-methyl-D-aspartate receptor antoagnonists in the treatment of depression: a perspective review. </span> <span class="source" tagx="source" title="source"> <i>Ther Adv Chronic Dis.</i> </span> <span class="year" tagx="year" title="year">2015</span> <span class="volume" tagx="volume" title="volume">6</span> <span class="issue" tagx="issue" title="issue">3</span> <span class="fpage" tagx="fpage" title="fpage">97</span> <span class="lpage" tagx="lpage" title="lpage">114</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25954495">25954495</a> </span> </span> </li> <li tag="ref"> <a name="ref22" /> <span class="label" tagx="label" title="label">22</span> <span class="element-citation'"> <span class="mixed-article-title" title="mixed-article-title">FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic. </span> <span class="source" tagx="source" title="source"> <i /> </span> <span class="comment">Available at:</span> </span> </li> <li tag="ref"> <a name="ref23" /> <span class="label" tagx="label" title="label">23</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kishi</span> <span class="given-names" tagx="given-names" title="given-names">T,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Matsunaga</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Oya</span> <span class="given-names" tagx="given-names" title="given-names">K,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Nomura</span> <span class="given-names" tagx="given-names" title="given-names">I,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ikuta</span> <span class="given-names" tagx="given-names" title="given-names">T,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Iwata</span> <span class="given-names" tagx="given-names" title="given-names">N.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Memantine for Alzheimer’s disease: an updated systematic review and meta-analysis. </span> <span class="source" tagx="source" title="source"> <i>J Alzheimers Dis.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">60</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">401</span> <span class="lpage" tagx="lpage" title="lpage">425</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/28922160">28922160</a> </span> </span> </li> <li tag="ref"> <a name="ref24" /> <span class="label" tagx="label" title="label">24</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Garido-Mesa</span> <span class="given-names" tagx="given-names" title="given-names">N,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zarzuelo</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Galvez</span> <span class="given-names" tagx="given-names" title="given-names">J.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Minocycline: far beyond an antibiotic.</span> <span class="source" tagx="source" title="source"> <i>Br J Pharmacol.</i> </span> <span class="year" tagx="year" title="year">2013</span> <span class="volume" tagx="volume" title="volume">169</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">337</span> <span class="lpage" tagx="lpage" title="lpage">352</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/23441623">23441623</a> </span> </span> </li> <li tag="ref"> <a name="ref25" /> <span class="label" tagx="label" title="label">25</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rosenblat</span> <span class="given-names" tagx="given-names" title="given-names">JD,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">McIntyre</span> <span class="given-names" tagx="given-names" title="given-names">RS.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials. </span> <span class="source" tagx="source" title="source"> <i>J Affect Disord.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">227</span> <span class="fpage" tagx="fpage" title="fpage">219</span> <span class="lpage" tagx="lpage" title="lpage">225</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29102836">29102836</a> </span> </span> </li> <li tag="ref"> <a name="ref26" /> <span class="label" tagx="label" title="label">26</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Savitz</span> <span class="given-names" tagx="given-names" title="given-names">JB,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Teague</span> <span class="given-names" tagx="given-names" title="given-names">TK,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Misaki</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial. </span> <span class="source" tagx="source" title="source"> <i>Transl Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">8</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">27</span> <span class="pub-id"> <a href="https://dx.doi.org/10.1038/s41398-017-0073-7.">10.1038/s41398-017-0073-7.</a> </span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29362444">29362444</a> </span> </span> </li> <li tag="ref"> <a name="ref27" /> <span class="label" tagx="label" title="label">27</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Murrough</span> <span class="given-names" tagx="given-names" title="given-names">JW,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Huryk</span> <span class="given-names" tagx="given-names" title="given-names">KM,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mao</span> <span class="given-names" tagx="given-names" title="given-names">X,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">A pilot study of minocycline for the treatment of bipolar depression: effects on cortical glutathione and oxidative stress in vivo. </span> <span class="source" tagx="source" title="source"> <i>J Affect Disord.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">1</span> <span class="issue" tagx="issue" title="issue">230</span> <span class="fpage" tagx="fpage" title="fpage">56</span> <span class="lpage" tagx="lpage" title="lpage">64</span> </span> </li> <li tag="ref"> <a name="ref28" /> <span class="label" tagx="label" title="label">28</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Deaking</span> <span class="given-names" tagx="given-names" title="given-names">B,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Suckling</span> <span class="given-names" tagx="given-names" title="given-names">J,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Barnes</span> <span class="given-names" tagx="given-names" title="given-names">TRE,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomized, double-blind, placebo-controlled trial. </span> <span class="source" tagx="source" title="source"> <i>Lancet Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">5</span> <span class="issue" tagx="issue" title="issue">11</span> <span class="fpage" tagx="fpage" title="fpage">885</span> <span class="lpage" tagx="lpage" title="lpage">894</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/30322824">30322824</a> </span> </span> </li> <li tag="ref"> <a name="ref29" /> <span class="label" tagx="label" title="label">29</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Levkovitz</span> <span class="given-names" tagx="given-names" title="given-names">Y,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mendlovich</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Riwkes</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. </span> <span class="source" tagx="source" title="source"> <i>J Clin Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2010</span> <span class="volume" tagx="volume" title="volume">71</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">138</span> <span class="lpage" tagx="lpage" title="lpage">148</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/19895780">19895780</a> </span> </span> </li> <li tag="ref"> <a name="ref30" /> <span class="label" tagx="label" title="label">30</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Xiang</span> <span class="given-names" tagx="given-names" title="given-names">YQ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zheng</span> <span class="given-names" tagx="given-names" title="given-names">W,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Wang</span> <span class="given-names" tagx="given-names" title="given-names">SB,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Adjunctive minocycline for schizophrenia: a meta-analysis of randomized controlled trials. </span> <span class="source" tagx="source" title="source"> <i>Eur Neuropsychopharmacol.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">27</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">8</span> <span class="lpage" tagx="lpage" title="lpage">18</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27919523">27919523</a> </span> </span> </li> <li tag="ref"> <a name="ref31" /> <span class="label" tagx="label" title="label">31</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Umeda</span> <span class="given-names" tagx="given-names" title="given-names">T,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ono</span> <span class="given-names" tagx="given-names" title="given-names">K,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sakai</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Rifampicin is a candidate preventive medicine against amyloid-beta and tau oligomers. </span> <span class="source" tagx="source" title="source"> <i>Brain.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">139</span> <span class="fpage" tagx="fpage" title="fpage">1568</span> <span class="lpage" tagx="lpage" title="lpage">1586</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27020329">27020329</a> </span> </span> </li> <li tag="ref"> <a name="ref32" /> <span class="label" tagx="label" title="label">32</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Yulug</span> <span class="given-names" tagx="given-names" title="given-names">B,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Hanoglu</span> <span class="given-names" tagx="given-names" title="given-names">L,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ozansov</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Therapeutic role of rifampicin in Alzheimer’s disease.</span> <span class="source" tagx="source" title="source"> <i>Psychiatry Clin Neurosci.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">72</span> <span class="issue" tagx="issue" title="issue">3</span> <span class="fpage" tagx="fpage" title="fpage">152</span> <span class="lpage" tagx="lpage" title="lpage">159</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29315976">29315976</a> </span> </span> </li> <li tag="ref"> <a name="ref33" /> <span class="label" tagx="label" title="label">33</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Loeb</span> <span class="given-names" tagx="given-names" title="given-names">MB,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Molloy</span> <span class="given-names" tagx="given-names" title="given-names">DW,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Smieja</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer’s disease. </span> <span class="source" tagx="source" title="source"> <i>J Am Geriatr Soc.</i> </span> <span class="year" tagx="year" title="year">2004</span> <span class="volume" tagx="volume" title="volume">52</span> <span class="fpage" tagx="fpage" title="fpage">381</span> <span class="lpage" tagx="lpage" title="lpage">387</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/14962152">14962152</a> </span> </span> </li> <li tag="ref"> <a name="ref34" /> <span class="label" tagx="label" title="label">34</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Iizuka</span> <span class="given-names" tagx="given-names" title="given-names">T,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Morimoto</span> <span class="given-names" tagx="given-names" title="given-names">K,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sasaki</span> <span class="given-names" tagx="given-names" title="given-names">Y,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Preventive effect of rifampicin on Alzheimer disease needs at least 450 mg daily for 1 year: an FDG-PET follow-up study. </span> <span class="source" tagx="source" title="source"> <i>Dement Geriatr Cogn Dis Extra.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">7</span> <span class="fpage" tagx="fpage" title="fpage">201</span> <span class="lpage" tagx="lpage" title="lpage">214</span> </span> </li> <li tag="ref"> <a name="ref35" /> <span class="label" tagx="label" title="label">35</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Molloy</span> <span class="given-names" tagx="given-names" title="given-names">DW,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Standish</span> <span class="given-names" tagx="given-names" title="given-names">TI,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zhou</span> <span class="given-names" tagx="given-names" title="given-names">Q,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Guyatt</span> <span class="given-names" tagx="given-names" title="given-names">G,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">DARAD Study group.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer’s disease: The DARAD trial. </span> <span class="source" tagx="source" title="source"> <i>Int J Geriatr Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2013</span> <span class="volume" tagx="volume" title="volume">28</span> <span class="fpage" tagx="fpage" title="fpage">463</span> <span class="lpage" tagx="lpage" title="lpage">470</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/22718435">22718435</a> </span> </span> </li> <li tag="ref"> <a name="ref36" /> <span class="label" tagx="label" title="label">36</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lizuka</span> <span class="given-names" tagx="given-names" title="given-names">T,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Morimoto</span> <span class="given-names" tagx="given-names" title="given-names">K,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sasaki</span> <span class="given-names" tagx="given-names" title="given-names">Y,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Preventive effect of rifampicin on Alzheimer disease needs at least 450 mg daily for 1 year: an FDG –PET follow-up study. </span> <span class="source" tagx="source" title="source"> <i>Dement Geriatr Cogn Dis Extra.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">7</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">204</span> <span class="lpage" tagx="lpage" title="lpage">214</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/28690634">28690634</a> </span> </span> </li> <li tag="ref"> <a name="ref37" /> <span class="label" tagx="label" title="label">37</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Peterson</span> <span class="given-names" tagx="given-names" title="given-names">TC,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Brown</span> <span class="given-names" tagx="given-names" title="given-names">IR.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Cysteamine in combination with N-acetylcysteine prevents acetaminophen-induced hepatotoxicity. </span> <span class="source" tagx="source" title="source"> <i>Can J Physiol Pharmacol.</i> </span> <span class="year" tagx="year" title="year">1992</span> <span class="volume" tagx="volume" title="volume">70</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">20</span> <span class="lpage" tagx="lpage" title="lpage">8</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/1581851">1581851</a> </span> </span> </li> <li tag="ref"> <a name="ref38" /> <span class="label" tagx="label" title="label">38</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Minarini</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ferrari</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Galleti</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects. </span> <span class="source" tagx="source" title="source"> <i>Expert Opin Drug Metab Toxicol.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">13</span> <span class="issue" tagx="issue" title="issue">3</span> <span class="fpage" tagx="fpage" title="fpage">279</span> <span class="lpage" tagx="lpage" title="lpage">292</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27766914">27766914</a> </span> </span> </li> <li tag="ref"> <a name="ref39" /> <span class="label" tagx="label" title="label">39</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Deepmala,</span> <span class="given-names" tagx="given-names" title="given-names">J,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Slattery</span> <span class="given-names" tagx="given-names" title="given-names">J,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kumar</span> <span class="given-names" tagx="given-names" title="given-names">N,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. </span> <span class="source" tagx="source" title="source"> <i>Neurosci Biobehav Rev.</i> </span> <span class="year" tagx="year" title="year">2015</span> <span class="volume" tagx="volume" title="volume">55</span> <span class="fpage" tagx="fpage" title="fpage">294</span> <span class="lpage" tagx="lpage" title="lpage">321</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25957927">25957927</a> </span> </span> </li> <li tag="ref"> <a name="ref40" /> <span class="label" tagx="label" title="label">40</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zhen</span> <span class="given-names" tagx="given-names" title="given-names">W,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zhang</span> <span class="given-names" tagx="given-names" title="given-names">QE,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cai</span> <span class="given-names" tagx="given-names" title="given-names">DB,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials. </span> <span class="source" tagx="source" title="source"> <i>Acta Psychiatr Scand.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">137</span> <span class="issue" tagx="issue" title="issue">5</span> <span class="fpage" tagx="fpage" title="fpage">391</span> <span class="lpage" tagx="lpage" title="lpage">400</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29457216">29457216</a> </span> </span> </li> <li tag="ref"> <a name="ref41" /> <span class="label" tagx="label" title="label">41</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sharma</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Gerbarg</span> <span class="given-names" tagx="given-names" title="given-names">P,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bottiglieri</span> <span class="given-names" tagx="given-names" title="given-names">T,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">S-Adenosylmethionine (SAMe) for neuropsychiatric disorders: a clinician-oriented review of research. </span> <span class="source" tagx="source" title="source"> <i>J Clin Psychiatry. </i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">78</span> <span class="issue" tagx="issue" title="issue">6</span> <span class="fpage" tagx="fpage" title="fpage">e656</span> <span class="lpage" tagx="lpage" title="lpage">e667</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/28682528">28682528</a> </span> </span> </li> <li tag="ref"> <a name="ref42" /> <span class="label" tagx="label" title="label">42</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Shaw</span> <span class="given-names" tagx="given-names" title="given-names">K,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Turner</span> <span class="given-names" tagx="given-names" title="given-names">J,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Del Mar</span> <span class="given-names" tagx="given-names" title="given-names">C.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Tryptophan and 5-hydroxytryptophan for depression.</span> <span class="source" tagx="source" title="source"> <i>Cochrane Database Syst Rev.</i> </span> <span class="year" tagx="year" title="year">2002</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">CD003198</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/11869656">11869656</a> </span> </span> </li> <li tag="ref"> <a name="ref43" /> <span class="label" tagx="label" title="label">43</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Hori</span> <span class="given-names" tagx="given-names" title="given-names">H,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kunugi</span> <span class="given-names" tagx="given-names" title="given-names">H.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Dopamine agonist- responsive depression.</span> <span class="source" tagx="source" title="source"> <i>Psychogeriatrics.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">13</span> <span class="issue" tagx="issue" title="issue">3</span> <span class="fpage" tagx="fpage" title="fpage">89</span> <span class="lpage" tagx="lpage" title="lpage">95</span> </span> </li> <li tag="ref"> <a name="ref44" /> <span class="label" tagx="label" title="label">44</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Corrigan</span> <span class="given-names" tagx="given-names" title="given-names">MH,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Denahan</span> <span class="given-names" tagx="given-names" title="given-names">AQ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Wright</span> <span class="given-names" tagx="given-names" title="given-names">CE,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ragual</span> <span class="given-names" tagx="given-names" title="given-names">RJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Evans</span> <span class="given-names" tagx="given-names" title="given-names">DL.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. </span> <span class="source" tagx="source" title="source"> <i>Depress Anxiety.</i> </span> <span class="year" tagx="year" title="year">2000</span> <span class="volume" tagx="volume" title="volume">11</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">58</span> <span class="lpage" tagx="lpage" title="lpage">65</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/10812530">10812530</a> </span> </span> </li> <li tag="ref"> <a name="ref45" /> <span class="label" tagx="label" title="label">45</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Yatham</span> <span class="given-names" tagx="given-names" title="given-names">LN,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kennedy</span> <span class="given-names" tagx="given-names" title="given-names">SH,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Parikh</span> <span class="given-names" tagx="given-names" title="given-names">SV,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Schaffer</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bond</span> <span class="given-names" tagx="given-names" title="given-names">DJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Frey</span> <span class="given-names" tagx="given-names" title="given-names">BN.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Canadian Network for mood and anxiety treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. </span> <span class="source" tagx="source" title="source"> <i>Bipolar Disord.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">20</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">97</span> <span class="lpage" tagx="lpage" title="lpage">170</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29536616">29536616</a> </span> </span> </li> <li tag="ref"> <a name="ref46" /> <span class="label" tagx="label" title="label">46</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Shingu</span> <span class="given-names" tagx="given-names" title="given-names">K,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kawai</span> <span class="given-names" tagx="given-names" title="given-names">I,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Yamada</span> <span class="given-names" tagx="given-names" title="given-names">K.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Thee cases of unipolar delusional depression responsive to L-dopa. </span> <span class="source" tagx="source" title="source"> <i>Folia Psychiatr Neurol Jpn.</i> </span> <span class="year" tagx="year" title="year">1979</span> <span class="volume" tagx="volume" title="volume">33</span> <span class="issue" tagx="issue" title="issue">4</span> <span class="fpage" tagx="fpage" title="fpage">511</span> <span class="lpage" tagx="lpage" title="lpage">515</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/535833">535833</a> </span> </span> </li> <li tag="ref"> <a name="ref47" /> <span class="label" tagx="label" title="label">47</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Koella</span> <span class="given-names" tagx="given-names" title="given-names">WP.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">CNS-related (side-)effects of beta blockers with special reference to mechanisms of action. </span> <span class="source" tagx="source" title="source"> <i>Eur J Clin Pharmacol.</i> </span> <span class="year" tagx="year" title="year">1985</span> <span class="volume" tagx="volume" title="volume">28</span> <span class="issue" tagx="issue" title="issue">Suppl</span> <span class="fpage" tagx="fpage" title="fpage">55</span> <span class="lpage" tagx="lpage" title="lpage">63</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/2865151">2865151</a> </span> </span> </li> <li tag="ref"> <a name="ref48" /> <span class="label" tagx="label" title="label">48</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cruickshank</span> <span class="given-names" tagx="given-names" title="given-names">JM.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">The clinical importance of cardioselectivity and lipophilicity in beta blockers. </span> <span class="source" tagx="source" title="source"> <i>Am Heart J.</i> </span> <span class="year" tagx="year" title="year">1980</span> <span class="volume" tagx="volume" title="volume">100</span> <span class="fpage" tagx="fpage" title="fpage">160</span> <span class="lpage" tagx="lpage" title="lpage">178</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/6105819">6105819</a> </span> </span> </li> <li tag="ref"> <a name="ref49" /> <span class="label" tagx="label" title="label">49</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ravaris</span> <span class="given-names" tagx="given-names" title="given-names">CL,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Friedman</span> <span class="given-names" tagx="given-names" title="given-names">MJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Hauri</span> <span class="given-names" tagx="given-names" title="given-names">PJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">McHugo</span> <span class="given-names" tagx="given-names" title="given-names">GJ.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients. </span> <span class="source" tagx="source" title="source"> <i>J Clin Psychopharmacol.</i> </span> <span class="year" tagx="year" title="year">1991</span> <span class="volume" tagx="volume" title="volume">11</span> <span class="issue" tagx="issue" title="issue">6</span> <span class="fpage" tagx="fpage" title="fpage">344</span> <span class="lpage" tagx="lpage" title="lpage">350</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/1770152">1770152</a> </span> </span> </li> <li tag="ref"> <a name="ref50" /> <span class="label" tagx="label" title="label">50</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Steenen</span> <span class="given-names" tagx="given-names" title="given-names">SA,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">van Wijk</span> <span class="given-names" tagx="given-names" title="given-names">AJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">van der Heijden </span> <span class="given-names" tagx="given-names" title="given-names">GJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">van Westrhenen</span> <span class="given-names" tagx="given-names" title="given-names">R,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">de Lange</span> <span class="given-names" tagx="given-names" title="given-names">G,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">de Jongh</span> <span class="given-names" tagx="given-names" title="given-names">A.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis. </span> <span class="source" tagx="source" title="source"> <i>J Psychopharmacol.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">30</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">128</span> <span class="lpage" tagx="lpage" title="lpage">139</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/26487439">26487439</a> </span> </span> </li> <li tag="ref"> <a name="ref51" /> <span class="label" tagx="label" title="label">51</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lonergan</span> <span class="given-names" tagx="given-names" title="given-names">MH,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Olivera-Figueroa</span> <span class="given-names" tagx="given-names" title="given-names">LA,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Pitman</span> <span class="given-names" tagx="given-names" title="given-names">RK,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Brunet</span> <span class="given-names" tagx="given-names" title="given-names">A.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Propranolol’s effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis. </span> <span class="source" tagx="source" title="source"> <i>J Psychiatry Neurosci.</i> </span> <span class="year" tagx="year" title="year">2013</span> <span class="volume" tagx="volume" title="volume">33</span> <span class="issue" tagx="issue" title="issue">4</span> <span class="fpage" tagx="fpage" title="fpage">222</span> <span class="lpage" tagx="lpage" title="lpage">231</span> </span> </li> <li tag="ref"> <a name="ref52" /> <span class="label" tagx="label" title="label">52</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Burbiel</span> <span class="given-names" tagx="given-names" title="given-names">JC.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Primary prevention of posttraumatic stress disorder: drugs and implications. </span> <span class="source" tagx="source" title="source"> <i>Mil Med Res.</i> </span> <span class="year" tagx="year" title="year">2015</span> <span class="volume" tagx="volume" title="volume">2</span> <span class="fpage" tagx="fpage" title="fpage">24</span> <span class="pub-id"> <a href="https://dx.doi.org/10.1186/s40779-015-0053-2.">10.1186/s40779-015-0053-2.</a> </span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/26504586">26504586</a> </span> </span> </li> <li tag="ref"> <a name="ref53" /> <span class="label" tagx="label" title="label">53</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Brunet</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Orr</span> <span class="given-names" tagx="given-names" title="given-names">SP,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Tremblay</span> <span class="given-names" tagx="given-names" title="given-names">H,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Robertson </span> <span class="given-names" tagx="given-names" title="given-names">K,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Nader</span> <span class="given-names" tagx="given-names" title="given-names">K,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Pitman</span> <span class="given-names" tagx="given-names" title="given-names">RK.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driver traumatic imagery in post-traumatic stress disorder. </span> <span class="source" tagx="source" title="source"> <i>J Psychiatr Res.</i> </span> <span class="year" tagx="year" title="year">2008</span> <span class="volume" tagx="volume" title="volume">42</span> <span class="issue" tagx="issue" title="issue">6</span> <span class="fpage" tagx="fpage" title="fpage">503</span> <span class="lpage" tagx="lpage" title="lpage">506</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/17588604">17588604</a> </span> </span> </li> <li tag="ref"> <a name="ref54" /> <span class="label" tagx="label" title="label">54</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Brunet</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Saumer</span> <span class="given-names" tagx="given-names" title="given-names">D,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lia</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Streiner</span> <span class="given-names" tagx="given-names" title="given-names">Dl,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Tremblay</span> <span class="given-names" tagx="given-names" title="given-names">J,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Pitman</span> <span class="given-names" tagx="given-names" title="given-names">RK.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Reduction of PTSD symptoms with pre-reactivation propranolol therapy : a randomized controlled trial. </span> <span class="source" tagx="source" title="source"> <i>Am J Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">175</span> <span class="issue" tagx="issue" title="issue">5</span> <span class="fpage" tagx="fpage" title="fpage">427</span> <span class="lpage" tagx="lpage" title="lpage">433</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29325446">29325446</a> </span> </span> </li> <li tag="ref"> <a name="ref55" /> <span class="label" tagx="label" title="label">55</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Shen</span> <span class="given-names" tagx="given-names" title="given-names">H,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Li</span> <span class="given-names" tagx="given-names" title="given-names">R,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Yan</span> <span class="given-names" tagx="given-names" title="given-names">R,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Adjunctive therapy with statins in schizophrenia patients : a meta-analysis and implications. </span> <span class="source" tagx="source" title="source"> <i>Psychiatry Res.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">262</span> <span class="fpage" tagx="fpage" title="fpage">84</span> <span class="lpage" tagx="lpage" title="lpage">93</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29427912">29427912</a> </span> </span> </li> <li tag="ref"> <a name="ref56" /> <span class="label" tagx="label" title="label">56</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Hayes</span> <span class="given-names" tagx="given-names" title="given-names">JF,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">lundi</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Wicks</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Association of hydroxylmethyl glutaryl coenzymes A reductase inhibitors, L-type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization and self-harm in individuals with serious mental illness. </span> <span class="source" tagx="source" title="source"> <i>JAMA Psychiatry. </i> </span> <span class="year" tagx="year" title="year">2019</span> <span class="volume" tagx="volume" title="volume">76</span> <span class="issue" tagx="issue" title="issue">4</span> <span class="fpage" tagx="fpage" title="fpage">382</span> <span class="lpage" tagx="lpage" title="lpage">390</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/30624557">30624557</a> </span> </span> </li> <li tag="ref"> <a name="ref57" /> <span class="label" tagx="label" title="label">57</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">El-Hage</span> <span class="given-names" tagx="given-names" title="given-names">W,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Leman</span> <span class="given-names" tagx="given-names" title="given-names">S,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Camus</span> <span class="given-names" tagx="given-names" title="given-names">V,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Belzung</span> <span class="given-names" tagx="given-names" title="given-names">C.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Mechanisms of antidepressant resistance.</span> <span class="source" tagx="source" title="source"> <i>Front Pharmacol.</i> </span> <span class="year" tagx="year" title="year">2013</span> <span class="volume" tagx="volume" title="volume">4</span> <span class="fpage" tagx="fpage" title="fpage">146</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/24319431">24319431</a> </span> </span> </li> <li tag="ref"> <a name="ref58" /> <span class="label" tagx="label" title="label">58</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kennedy</span> <span class="given-names" tagx="given-names" title="given-names">SH,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lam</span> <span class="given-names" tagx="given-names" title="given-names">RW,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">McIntyre</span> <span class="given-names" tagx="given-names" title="given-names">RS,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. </span> <span class="source" tagx="source" title="source"> <i>Pharmacological Treatments. Can J Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">61</span> <span class="issue" tagx="issue" title="issue">9</span> <span class="fpage" tagx="fpage" title="fpage">540</span> <span class="lpage" tagx="lpage" title="lpage">560</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27486148">27486148</a> </span> </span> </li> <li tag="ref"> <a name="ref59" /> <span class="label" tagx="label" title="label">59</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Touma</span> <span class="given-names" tagx="given-names" title="given-names">KTB,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zoucha</span> <span class="given-names" tagx="given-names" title="given-names">AM,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Scarff</span> <span class="given-names" tagx="given-names" title="given-names">JR.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Liothyronine for depression: a review and guidance for safety monitoring. </span> <span class="source" tagx="source" title="source"> <i>Innov Clin Neurosci.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">14</span> <span class="issue" tagx="issue" title="issue">3-4</span> <span class="fpage" tagx="fpage" title="fpage">24</span> <span class="lpage" tagx="lpage" title="lpage">29</span> </span> </li> <li tag="ref"> <a name="ref60" /> <span class="label" tagx="label" title="label">60</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Parmentier</span> <span class="given-names" tagx="given-names" title="given-names">T,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sienaert</span> <span class="given-names" tagx="given-names" title="given-names">P.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">The use of triiodothyronine (T3) in the treatment of bipolar depression: A review of the literature. </span> <span class="source" tagx="source" title="source"> <i>J Affect Disord.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">229</span> <span class="fpage" tagx="fpage" title="fpage">410</span> <span class="lpage" tagx="lpage" title="lpage">414</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29331701">29331701</a> </span> </span> </li> <li tag="ref"> <a name="ref61" /> <span class="label" tagx="label" title="label">61</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Schaffer</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">McIntosh</span> <span class="given-names" tagx="given-names" title="given-names">D,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Goldstein</span> <span class="given-names" tagx="given-names" title="given-names">BI,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">The canadian network for mood and anxiety reatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. </span> <span class="source" tagx="source" title="source"> <i>Ann Clin Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2012</span> <span class="volume" tagx="volume" title="volume">24</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">6</span> <span class="lpage" tagx="lpage" title="lpage">22</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/22303519">22303519</a> </span> </span> </li> <li tag="ref"> <a name="ref62" /> <span class="label" tagx="label" title="label">62</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Katzman</span> <span class="given-names" tagx="given-names" title="given-names">MA,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bleau</span> <span class="given-names" tagx="given-names" title="given-names">P,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Blier</span> <span class="given-names" tagx="given-names" title="given-names">P,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. </span> <span class="source" tagx="source" title="source"> <i>BMC Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2014</span> <span class="volume" tagx="volume" title="volume">14</span> <span class="issue" tagx="issue" title="issue">Suppl 1</span> <span class="fpage" tagx="fpage" title="fpage">S1</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25081580">25081580</a> </span> </span> </li> <li tag="ref"> <a name="ref63" /> <span class="label" tagx="label" title="label">63</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Yildiz</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Nikodem</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Vieta</span> <span class="given-names" tagx="given-names" title="given-names">E,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Correll</span> <span class="given-names" tagx="given-names" title="given-names">CU,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Baldessarini</span> <span class="given-names" tagx="given-names" title="given-names">RJ.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">A network meta- analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. </span> <span class="source" tagx="source" title="source"> <i>Psychol Med.</i> </span> <span class="year" tagx="year" title="year">2015</span> <span class="volume" tagx="volume" title="volume">45</span> <span class="fpage" tagx="fpage" title="fpage">299</span> <span class="lpage" tagx="lpage" title="lpage">317</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25036226">25036226</a> </span> </span> </li> <li tag="ref"> <a name="ref64" /> <span class="label" tagx="label" title="label">64</span> <span class="element-citation'"> <span class="mixed-article-title" title="mixed-article-title">Anti-inflammatoires non stéroïdiens (AINS) et complications infectieuses graves – Point d’information. </span> <span class="source" tagx="source" title="source"> <i /> </span> <span class="comment">Available at:</span> </span> </li> <li tag="ref"> <a name="ref65" /> <span class="label" tagx="label" title="label">65</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Massoud</span> <span class="given-names" tagx="given-names" title="given-names">F,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Gauthier</span> <span class="given-names" tagx="given-names" title="given-names">S.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Update on the pharmacological treatment of Alzheimer’s disease. </span> <span class="source" tagx="source" title="source"> <i>Curr Neuropharmacol.</i> </span> <span class="year" tagx="year" title="year">2010</span> <span class="volume" tagx="volume" title="volume">8</span> <span class="issue" tagx="issue" title="issue">1</span> <span class="fpage" tagx="fpage" title="fpage">69</span> <span class="lpage" tagx="lpage" title="lpage">80</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/20808547">20808547</a> </span> </span> </li> <li tag="ref"> <a name="ref66" /> <span class="label" tagx="label" title="label">66</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Qi</span> <span class="given-names" tagx="given-names" title="given-names">W,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Gevonden</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Shaly</span> <span class="given-names" tagx="given-names" title="given-names">A.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Preventionof post-traumatic stress disorder after trauma : current evidence and future directions. </span> <span class="source" tagx="source" title="source"> <i>Curr Psychiatry Rep.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="fpage" tagx="fpage" title="fpage">18</span> <span class="lpage" tagx="lpage" title="lpage">20</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/26797860">26797860</a> </span> </span> </li> <li tag="ref"> <a name="ref67" /> <span class="label" tagx="label" title="label">67</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sijbrandij</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kleiboer</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bisson</span> <span class="given-names" tagx="given-names" title="given-names">JI,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Barbui</span> <span class="given-names" tagx="given-names" title="given-names">C,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cuijpers</span> <span class="given-names" tagx="given-names" title="given-names">P.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis. </span> <span class="source" tagx="source" title="source"> <i>Lancet Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2015</span> <span class="volume" tagx="volume" title="volume">2</span> <span class="issue" tagx="issue" title="issue">5</span> <span class="fpage" tagx="fpage" title="fpage">413</span> <span class="lpage" tagx="lpage" title="lpage">421</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/26360285">26360285</a> </span> </span> </li> <li tag="ref"> <a name="ref68" /> <span class="label" tagx="label" title="label">68</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Baldwin</span> <span class="given-names" tagx="given-names" title="given-names">DS,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Anderson</span> <span class="given-names" tagx="given-names" title="given-names">IM,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Nutt</span> <span class="given-names" tagx="given-names" title="given-names">DJ,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">et al.</span> <span class="given-names" tagx="given-names" title="given-names" /> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. </span> <span class="source" tagx="source" title="source"> <i>J Psychopharmacol.</i> </span> <span class="year" tagx="year" title="year">2014</span> <span class="volume" tagx="volume" title="volume">28</span> <span class="issue" tagx="issue" title="issue">5</span> <span class="fpage" tagx="fpage" title="fpage">403</span> <span class="lpage" tagx="lpage" title="lpage">349</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/24713617">24713617</a> </span> </span> </li> <li tag="ref"> <a name="ref69" /> <span class="label" tagx="label" title="label">69</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">De la Torre</span> <span class="given-names" tagx="given-names" title="given-names">JC.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Cerebral perfusion enhancing interventions: a new strategy for the prevention of Alzheimer Dementia. </span> <span class="source" tagx="source" title="source"> <i>Brain Pathol.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">26</span> <span class="issue" tagx="issue" title="issue">5</span> <span class="fpage" tagx="fpage" title="fpage">618</span> <span class="lpage" tagx="lpage" title="lpage">631</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27324946">27324946</a> </span> </span> </li> <li tag="ref"> <a name="ref70" /> <span class="label" tagx="label" title="label">70</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">De la Torre</span> <span class="given-names" tagx="given-names" title="given-names">JC.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Carotid artery ultrasound and echocardiography testing to lower the prevalence of Alzheimer’s disease. </span> <span class="source" tagx="source" title="source"> <i>J Stroke Cerebreovasc Dis.</i> </span> <span class="year" tagx="year" title="year">2009</span> <span class="volume" tagx="volume" title="volume">18</span> <span class="issue" tagx="issue" title="issue">4</span> <span class="fpage" tagx="fpage" title="fpage">319</span> <span class="lpage" tagx="lpage" title="lpage">28</span> </span> </li> <li tag="ref"> <a name="ref71" /> <span class="label" tagx="label" title="label">71</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Coca</span> <span class="given-names" tagx="given-names" title="given-names">A,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Monteagudo</span> <span class="given-names" tagx="given-names" title="given-names">E,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Coménech</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Camafort</span> <span class="given-names" tagx="given-names" title="given-names">M,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sierra</span> <span class="given-names" tagx="given-names" title="given-names">C.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Can the treatment of hypertension in the middle-aged prevent dementia in the elderly? </span> <span class="source" tagx="source" title="source"> <i>High Blood Press Cardiovasc Prev.</i> </span> <span class="year" tagx="year" title="year">2016</span> <span class="volume" tagx="volume" title="volume">23</span> <span class="issue" tagx="issue" title="issue">2</span> <span class="fpage" tagx="fpage" title="fpage">97</span> <span class="lpage" tagx="lpage" title="lpage">104</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27075454">27075454</a> </span> </span> </li> <li tag="ref"> <a name="ref72" /> <span class="label" tagx="label" title="label">72</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Elamoshy</span> <span class="given-names" tagx="given-names" title="given-names">R,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bird</span> <span class="given-names" tagx="given-names" title="given-names">Y,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Thorpe</span> <span class="given-names" tagx="given-names" title="given-names">L,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Moraros</span> <span class="given-names" tagx="given-names" title="given-names">J.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Risk of depression and suicidality among diabetic patients: a systematic review and meta-analysis. </span> <span class="source" tagx="source" title="source"> <i>J Clin Med.</i> </span> <span class="year" tagx="year" title="year">2018</span> <span class="volume" tagx="volume" title="volume">7</span> <span class="issue" tagx="issue" title="issue">11</span> <span class="fpage" tagx="fpage" title="fpage">445</span> <span class="pub-id"> <a href="https://dx.doi.org/10.3390/jcm7110445.">10.3390/jcm7110445.</a> </span> </span> </li> <li tag="ref"> <a name="ref73" /> <span class="label" tagx="label" title="label">73</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Harriger</span> <span class="given-names" tagx="given-names" title="given-names">JA,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Thompson</span> <span class="given-names" tagx="given-names" title="given-names">JK.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Psychological consequences of obesity: weigh bias and body image in overweight and obese youth. </span> <span class="source" tagx="source" title="source"> <i>Int Rev Psychiatry.</i> </span> <span class="year" tagx="year" title="year">2012</span> <span class="volume" tagx="volume" title="volume">24</span> <span class="issue" tagx="issue" title="issue">3</span> <span class="fpage" tagx="fpage" title="fpage">247</span> <span class="lpage" tagx="lpage" title="lpage">253</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/22724646">22724646</a> </span> </span> </li> <li tag="ref"> <a name="ref74" /> <span class="label" tagx="label" title="label">74</span> <span class="element-citation'"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rajan</span> <span class="given-names" tagx="given-names" title="given-names">TM,</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Menon</span> <span class="given-names" tagx="given-names" title="given-names">V.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Psychiatric disorders and obesity: a review of association studies. </span> <span class="source" tagx="source" title="source"> <i>J Postgrad Med.</i> </span> <span class="year" tagx="year" title="year">2017</span> <span class="volume" tagx="volume" title="volume">63</span> <span class="issue" tagx="issue" title="issue">3</span> <span class="fpage" tagx="fpage" title="fpage">182</span> <span class="lpage" tagx="lpage" title="lpage">190</span> <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/28695871">28695871</a> </span> </span> </li> </ul> </div> </div>  </body></html>